Substituting carmustine for lomustine is safe and effective in the treatment of relapsed or refractory Lymphoma-a retrospective study from the BSBMT (BEAM versus LEAM)

Bone Marrow Transplant. 2021 Mar;56(3):730-732. doi: 10.1038/s41409-020-01071-2. Epub 2020 Sep 29.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carmustine* / therapeutic use
  • Cytarabine / therapeutic use
  • Etoposide / therapeutic use
  • Humans
  • Lomustine / therapeutic use
  • Lymphoma* / drug therapy
  • Melphalan / therapeutic use
  • Retrospective Studies
  • Transplantation Conditioning
  • Transplantation, Autologous

Substances

  • Cytarabine
  • Etoposide
  • Lomustine
  • Melphalan
  • Carmustine